Pre-Tax Profit Margin: Earnings before taxes as a portion of total revenue. Calculated as: Pre-Tax Income / Total Revenues
Stoke Therapeutics, Inc. (STOK) had Pre-Tax Profit Margin of -802.75% for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
$6.23M |
|
$-50.00M |
|
-- |
|
$6.23M |
|
$59.65M |
|
$-53.42M |
|
$3.42M |
|
$-50.00M |
|
$-50.00M |
|
$-50.00M |
|
$-50.00M |
|
$-50.00M |
|
$-50.00M |
|
$-53.42M |
|
$-53.34M |
|
63.06M |
|
63.06M |
|
$-0.79 |
|
$-0.79 |
|
| Balance Sheet Financials | |
$366.68M |
|
$3.40M |
|
$76.60M |
|
$443.28M |
|
$40.81M |
|
-- |
|
$7.59M |
|
$48.40M |
|
$394.88M |
|
$394.88M |
|
$394.88M |
|
62.24M |
|
| Cash Flow Statement Financials | |
$-60.58M |
|
$50.69M |
|
$84.33M |
|
$84.94M |
|
$159.38M |
|
$74.44M |
|
$8.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
8.99 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-857.57% |
|
-857.57% |
|
-- |
|
|
Pre-Tax Profit Margin |
-802.75% |
-802.75% |
|
$-60.94M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
1.01 |
|
88.73 |
|
-12.66% |
|
-12.66% |
|
-11.28% |
|
-12.66% |
|
$6.34 |
|
$-0.97 |
|
$-0.96 |
|